Bausch Health Companies Inc.

04/25/2019 | Press release | Distributed by Public on 04/25/2019 05:08

Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma To Develop And Commercialize Late Stage Investigational S1P Modulator For The Treatment Of[...]